Company intelligence / Profile preview

Nanomedic Technologies

Ownership: Private
Development stage: Commercial

Overview

Nanomedic Technologies has commercialized the Spincare System, a portable electrospinning device that creates a nanofibrous layer directly on patients’ wounds to promote healing. The system is CE-marked and distributed globally for advanced wound care. Clinical results indicate rapid healing and reduced infection risk; however, detailed clinical trial data are not publicly available in the search results[2][5].

Therapeutic areas: Dermatology
Modalities: DeviceNanoparticle (via electrospun nanofibers)Hydrogel-based drug delivery therapy (implied by wound care application)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

SpinCare

Commercial

Indications: Burns, Chronic wounds, Skin disorders, Donor site wounds

Beyond the preview

Go deeper on Nanomedic Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanomedic Technologies.

Explore the full profile